ARCHIVES

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

This article is from The Cancer Letter archive.

Vol. 06 No. 17 | April 25, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

In Brief: M.D. Anderson Selects Raphael Pollock To Lead Surgery Div.; S.F. VA Picks Norton

September 12, 1997

New Organ Systems Concept Flow Discussed

October 18, 1985

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013

Eight CCRU, 20 CCSP Applications Submitted, Quality Is ‘Heartening’

November 19, 1982